| Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway R Pradhan, S Paul, B Das, S Sinha, SR Dash, M Mandal, CN Kundu The Journal of Nutritional Biochemistry 113, 109257, 2023 | 21 | 2023 |
| Quinacrine and Curcumin in combination decreased the breast cancer angiogenesis by modulating ABCG2 via VEGF A D Nayak, S Paul, C Das, S Bhal, CN Kundu Journal of Cell Communication and Signaling 17 (3), 609-626, 2023 | 17 | 2023 |
| Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells CNK Biswajit Das, Somya Ranjan Dash, Harun Patel, Saptarshi Sinha ... Phytomedicine, 154914, 2023 | 14 | 2023 |
| Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping S Chatterjee, AK Dhal, S Paul, S Sinha, B Das, SR Dash, CN Kundu Journal of Cancer Research and Clinical Oncology 148 (12), 3521-3535, 2022 | 14 | 2022 |
| Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway S Sinha, S Chatterjee, S Paul, B Das, SR Dash, C Das, CN Kundu Experimental Cell Research 420 (1), 113338, 2022 | 14 | 2022 |
| NIR irradiation enhances the apoptotic potentiality of quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells SR Dash, S Chatterjee, S Sinha, B Das, S Paul, R Pradhan, C Sethy, ... Nanomedicine: Nanotechnology, Biology and Medicine 40, 102502, 2022 | 14 | 2022 |
| Targeting cancer stem cells in the tumor microenvironment: An emerging role of PARP inhibitors S Paul, S Sinha, CN Kundu Pharmacological Research 184, 106425, 2022 | 11 | 2022 |
| Exploration of Benzo [b] carbazole-6, 11-diones as anticancer agents: Synthesis and studies of hTopoIIα inhibition and apoptotic effects S Sisodiya, S Paul, H Chaudhary, P Grewal, G Kumar, DP Daniel, B Das, ... Bioorganic & Medicinal Chemistry Letters 49, 128274, 2021 | 10 | 2021 |
| Near-infrared enhances antiangiogenic potentiality of quinacrine-gold hybrid nanoparticles in breast cancer stem cells via deregulation of HSP-70/TGF-β SR Dash, B Das, C Das, S Sinha, S Paul, R Pradhan, CN Kundu Nanomedicine 18 (1), 19-33, 2023 | 9 | 2023 |
| Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells S Paul, S Chatterjee, S Sinha, SR Dash, R Pradhan, B Das, K Goutam, ... Expert Opinion on Therapeutic Targets 27 (10), 999-1015, 2023 | 7 | 2023 |
| Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells B Das, C Sethy, S Chatterjee, SR Dash, S Sinha, S Paul, K Goutam, ... Journal of Cell Communication and Signaling 17 (4), 1371-1388, 2023 | 4 | 2023 |
| Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300 C Das, SR Dash, S Sinha, S Paul, B Das, S Bhal, C Sethy, CN Kundu Medical Oncology 40 (12), 351, 2023 | 4 | 2023 |
| Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through … R Pradhan, S Paul, SS Acharya, S Sinha, SR Dash, CN Kundu The Journal of Nutritional Biochemistry 125, 109568, 2024 | 3 | 2024 |
| Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60 … S Sinha, S Paul, SS Acharya, C Das, SR Dash, S Bhal, R Pradhan, B Das, ... Medical Oncology 41 (2), 49, 2024 | 2 | 2024 |
| Design, synthesis, and anticancer activity of some novel 1H-benzo [d] imidazole-5-carboxamide derivatives as fatty acid synthase inhibitors S Singh, S Paul, NF Brás, CN Kundu, C Karthikeyan, NSHN Moorthy Bioorganic Chemistry 138, 106658, 2023 | 1 | 2023 |
| Design, synthesis and biological evaluation of Novel 1H-benzo [d] imidazole derivatives as Fatty Acid Synthase (FASN) inhibitors for cancer treatment S Singh, S Paul, C Karthikeyan, NF Brás, CN Kundu, NSHN Moorthy Medical Sciences Forum 14 (1), 117, 2022 | | 2022 |
Chanakya Nath KunduProfessor, KIIT school of Biotechnology, KIIT University, Orissa, India在 kiitbiotech.ac.in 的电子邮件经过验证
